NewAmsterdam Pharma NAMS
NASDAQ NAMS
$19.18 +0.20 (+1.05%)
At close: Nov 10, 2026 · 4:00 PM EST

NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026)

Updated

NewAmsterdam Pharma (NAMS) posted Other Assets of $2.59 million for Q1 2026.

Analysis

NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2023, NewAmsterdam Pharma's Other Assets came in at $35,000, down 77.6% from FY2022.

  • In prior years, NewAmsterdam Pharma's Other Assets was $156,000 in FY2022.
  • The Q1 2026 figure stands as the lowest quarterly Other Assets since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 15.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.42 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 700.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.90 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.02 Bn
10 NewAmsterdam Pharma 2.30 Bn -236.30 Mn - 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.50 Mn
Jun 30, 2026 1.36 Mn
Mar 31, 2026 2.59 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2024 8,000.00
Mar 31, 2024 16,000.00
Dec 31, 2023 35,000.00
Jun 30, 2023 101,072.68
Dec 31, 2022 156,000.00
API Access

NewAmsterdam Pharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEY